nach oben

Erschienen in:

05.07.2019 | Fortbildung

Vitamin- und Mineralstoffpräparate

Sinn und Unsinn von Supplementierung in der Onkologie

verfasst von: Prof. Dr. med. Karsten Münstedt

Erschienen in: gynäkologie + geburtshilfe | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Gerade onkologische Patienten setzen oft große Hoffnungen auf im Internet be- und erworbene Nahrungsergänzungsmittel. Die Datenlage zum Nutzen der Supplementierung ist jedoch dünn — und „viel hilft viel“ gilt hier keinesfalls. Vielmehr birgt Überversorgung häufig unabwägbare Risiken.

Drozdoff L et al. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy. BMC Complement Altern Med. 2018; 18: 259CrossRef

Fremd C et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Arch Gynecol Obstet. 2017; 295: 1239–45CrossRef

Münstedt K et al. Unconventional cancer therapy—survey of patients with gynaecological malignancy. Arch Gynecol Obstet. 1996; 258: 81–8PubMed

https://www.iqvia.com/media/iqvia/pdfs/cese/germany/publikationen/infografik/nahrungsergnzungsmittel-infografik-iqvia-052018.pdf?la=de-de&hash=FF5C297D9F0744CFB2D59EAE2436DC1A7D8CC217&_=1528367860467; zugegriffen am 27.2.2019

Calabrese EJ et al. U-shaped dose-responses in biology, toxicology, and public health. Annu Rev Public Health. 2001; 22: 15–33CrossRef

Kim M et al. Reuniting overnutrition and undernutrition, macronutrients, and micronutrients. Diabetes Metab Res Rev. 2018; https://doi.org/10.1002/dmrr.3072CrossRef

Goodwin PJ et al. Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol. 2003; 21: 2500–7CrossRef

Goyal A et al. Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults. Cancer Epidemiol Biomarkers Prev. 2013; 22: 2202–11CrossRef

Mücke R et al. Selenium in radiation oncology-15 years of experiences in Germany. Nutrients. 2018; http://doi.org/c258

10.

Biesalski HK, Tinz J. Multivitamin/mineral supplements: Rationale and safety — a systematic review. Nutrition. 2017; 33: 76–82CrossRef

11.

Perna L et al. Public health implications of standardized 25-hydroxyvitamin D levels: a decrease in the prevalence of vitamin D deficiency among older women in Germany. Prev Med. 2012; 55: 228–32CrossRef

12.

Troesch B et al. Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br J Nutr. 2012; 108: 692–8CrossRef

13.

Liu Z et al. Trace elements and chemotherapy sensitivity. Biol Trace Elem Res. 2016; 173: 283–90CrossRef

14.

Vadgama JV et al. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res. 2000; 20: 1391–414PubMed

15.

Li Z et al. Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells. Mol Cancer Ther. 2008; 7: 3056–63CrossRef

16.

Vieira ML et al. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food. 2015; 18: 109–17CrossRef

17.

Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol. 2004; 93: 320–7CrossRef

18.

Lippman SM et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39–51CrossRef

19.

Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr. 2011; 65: 1016–26CrossRef

20.

Zheng Y et al. Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One. 2013; http://doi.org/c26b

21.

Ditsch N et al. The association between vitamin D receptor expression and prolonged overall survival in breast cancer. J Histochem Cytochem. 2012; 60: 121–9CrossRef

22.

Li M et al. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014; 99: 2327–36CrossRef

23.

Maalmi H et al. Association between blood 25-hydroxyvitamin D levels and survival in colorectal cancer patients: an updated systematic review and meta-analysis. Nutrients. 2018; http://doi.org/c259

24.

Bittenbring JT et al. Vitamin d deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol. 2014; 32: 3242–8CrossRef

25.

Zeichner SB et al. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer. 2015; https://doi.org/10.1016/j.clbc.2014.08.001CrossRef

26.

Fink M. Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia. J Clin Oncol. 2011; https://doi.org/10.1200/JCO.2010.31.5317CrossRef

27.

Chiba A et al. Serum vitamin D levels affect pathologic complete response in patients undergoing neoadjuvant systemic therapy for operable breast cancer. Clin Breast Cancer. 2018; 18: 144–9CrossRef

28.

Shahvazi S et al. The effect of vitamin D supplementation on prostate cancer: a systematic review and meta-analysis of clinical trials. Horm Metab Res. 2019; 51: 11–21CrossRef

29.

Hu X et al. Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies. PLoS One. 2017; http://doi.org/gbsvsr

30.

Goh YI et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Clin Pharmacol Ther. 2007; 81: 685–91CrossRef

31.

Veettil SK et al. Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Medicine (Baltimore). 2017; http://doi.org/c257

32.

Seely D et al. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 2012; 11: 293–303CrossRef

33.

Harris HR et al. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer. 2014; 50: 1223–31CrossRef

34.

Kraft M et al. L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)- a randomized multicentre trial. Nutr J. 2012; 11: 52CrossRef

35.

Hershman DL et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 2013; 31: 2627–33CrossRef

36.

Marx W et al. Efficacy and effectiveness of carnitine supplementation for cancer-related fatigue: a systematic literature review and meta-analysis. Nutrients. 2017; http://doi.org/c26c

37.

Bjelakovic G et al. Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One. 2013; http://doi.org/c26d

38.

Tanvetyanon T et al. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands. Cancer. 2008; 113: 150–7CrossRef

39.

Klein EA et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011; 306: 1549–56CrossRef

40.

Miller ER 3rd et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005; 142: 37–46CrossRef

41.

Bjelakovic G et al. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther. 2006; 24: 281–91CrossRef

42.

Macpherson H et al. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013; 97: 437–44CrossRef

43.

Zhang SL et al. Effect of vitamin B supplementation on cancer incidence, death due to cancer, and total mortality: A PRISMA-compliant cumulative meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016; http://doi.org/c26f

44.

Jacobs C et al. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist. 2015; 20: 210–23CrossRef

45.

Kim K et al. High-dose vitamin C injection to cancer patients may promote thrombosis through procoagulant activation of erythrocytes. Toxicol Sci. 2015; 147: 350–9CrossRef

46.

Colliou E et al. Oxalate nephropathy following vitamin C intake within intensive care unit. Clin Nephrol. 2017; 88: 354–8CrossRef

47.

Mochamat et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project. J Cachexia Sarcopenia Muscle. 2017; 8: 25–39CrossRef

48.

S3-Leitline der Deutschen Gesellschaft für Ernährungsmedizin e.V. (DGEM): Klinische Ernährung in der Onkologie; https://www.dgem.de/sites/default/files/PDFs/Leitlinien/S3-Leitlinien/073-006l_S3_Klin_Ern%C3%A4hrung_in_der_Onkologie_2015-10.pdf; zugegriffen am 27.2.2019

Titel: Vitamin- und Mineralstoffpräparate
Sinn und Unsinn von Supplementierung in der Onkologie
verfasst von: Prof. Dr. med. Karsten Münstedt
Publikationsdatum: 05.07.2019
Verlag: Springer Medizin
Erschienen in: gynäkologie + geburtshilfe / Ausgabe 4/2019
Print ISSN: 1439-3557
Elektronische ISSN: 2196-6435
DOI: https://doi.org/10.1007/s15013-019-1769-y

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Springer Medizin

Sinn und Unsinn von Supplementierung in der Onkologie

Zusammenfassung

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Einfach abonnieren: www.gynforlife.com — der Praxis-Newsletter für Ihre Patientinnen

Jeder zusätzliche Kathetertag erhöht Gefahr für Harnwegsinfekt

Kalzium nützt nicht viel gegen Präeklampsie

CME: Therapie des metastasierten Mammakarzinoms

Tampon-Alternative Menstruationstasse

Impfen in der gynäkologischen Praxis

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie